U.S. Markets close in 5 hrs 9 mins

Syncom Formulations India Ltd (SYNCOM.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
5.15-0.04 (-0.77%)
At close: 3:13PM IST
Full screen
Previous Close5.19
Open5.27
Bid0.00 x
Ask0.00 x
Day's Range5.02 - 5.27
52 Week Range1.48 - 9.49
Volume19,965
Avg. Volume204,515
Market Cap4.02B
BetaN/A
PE Ratio (TTM)39.62
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Syncom Formulation India Ltd.: Gathering momentum, can it sustain its performance?
    Capital Cubelast year

    Syncom Formulation India Ltd.: Gathering momentum, can it sustain its performance?

    Syncom Formulation India Ltd. relative valuation is NEUTRAL and it has a fundamental analysis score of 75. Our analysis is based on comparing Syncom Formulation India Ltd. with the following peers – Medicamen Biotech Limited, Plethico Pharmaceuticals Ltd., NATCO Pharma Limited and Orchid Pharma Limited (531146-IN, 532739-IN, 524816-IN and 524372-IN). Syncom Formulation India Ltd. has […]

  • Syncom Formulation India Ltd. : Undervalued relative to peers, but don’t ignore the other factors
    Capital Cubelast year

    Syncom Formulation India Ltd. : Undervalued relative to peers, but don’t ignore the other factors

    Syncom Formulation India Ltd. relative valuation is now UNDERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 78.Our analysis is based on comparing Syncom Formulation India Ltd. with the following peers – Medicamen Biotech Limited, Plethico Pharmaceuticals Ltd., NATCO Pharma Limited and Orchid Pharma Limited (531146-IN, 532739-IN, 524816-IN and 524372-IN).Relative ValuationSyncom […] (Read more...) The post Syncom Formulation India Ltd. : Undervalued relative to peers, but don’t ignore the other factors appeared first on CapitalCube.

  • Syncom Formulation India Ltd.: Price momentum supported by strong fundamentals
    Capital Cubelast year

    Syncom Formulation India Ltd.: Price momentum supported by strong fundamentals

    Syncom Formulation India Ltd. relative valuation is NEUTRAL and it has a fundamental analysis score of 72.Our analysis is based on comparing Syncom Formulation India Ltd. with the following peers – Medicamen Biotech Limited, Plethico Pharmaceuticals Ltd., NATCO Pharma Limited and Orchid Pharma Limited (531146-IN, 532739-IN, 524816-IN and 524372-IN).Syncom Formulation India Ltd. has shown underwhelming […] (Read more...) The post Syncom Formulation India Ltd.: Price momentum supported by strong fundamentals appeared first on CapitalCube.